StockWatch
·
MODIS NAVNIRMAN · Q2 FY27 · THE VERDICT

Strong Growth, Delayed Cash — Execution Risk Priced In

Modis delivered 53% YoY revenue growth and margin expansion to 20.96%, yet H1 operating cash flow turned negative ₹16.51 Crore. Management's FY28 cash recovery guidance reveals the real constraint: liquidity, not profitability.

Q2 FY27 resultsMODISModis Navnirman Ltd29 Oct 2026 · 6 min read
H1 Revenue Growth

₹127.64 Cr

+53% YoY; projects executing on time

H1 Operating Cash Flow

-₹16.51 Cr

Inventory & project investment; recovery pushed to FY28

Modis Navnirman turned in a credible operational quarter — H1 revenue of ₹127.64 Crore (+53% YoY), EBITDA margin expanding to 20.96% in Q2, and ₹19.08 Crore of PAT up 59%. The redevelopment strategy is firing: two major projects launched (Icon, Avenue), order book swelling to ₹202 Crore in sales, and per-sq-ft realization holding at ₹25,724 despite material cost headwinds. But the real story sits below the headline: H1 operating cash flow turned negative ₹16.51 Crore, and management now guides cash recovery only to FY28, not H2 FY27. The quarter proves execution momentum. The call exposes the cost: liquidity tightness while three major projects rush toward March 31 FY27 completion.

Where the growth came from — and why it doesn't yet pay cash

Revenue growth is organic. H1 revenue of ₹127.64 Crore reflects ramp-up across six ongoing projects, with Rashmi Icon and Rashmi Avenue (both launched H1) driving 40%-plus of the sales value jump. Per-sq-ft realization of ₹25,724 on 78,560 sq ft sold narrows the margin compression that would have come from raw volume play; instead, Modis's selective project mix and Mumbai location premium are holding pricing power even as material costs stabilized (they spiked during war disruption; that pass-through is now behind them). EBITDA margin of 20.96% in Q2 is up 96 bps quarter-on-quarter, validating management's case that margin *expansion* comes as projects shift from early-stage (high inventory drag) to completion stage (higher margins, faster cash collection). That sequencing is sound in theory.

But the negative H1 operating cash flow of -₹16.51 Crore is the throttle. The ₹156 Crore in committed sales revenue that hasn't yet been recognized sits in unfinished projects. When Rashmi Square (80% complete), Rashmi Signature (61% complete), and Rashmi Delight/Manorath (55–51% complete) finally handover, the cash will follow — but management explicitly deferred that inflection to FY28, not H2 FY27. That timing slip matters: it means liquidity remains constrained through March 31 FY27, when three major projects must complete. If any slips, working capital pressure intensifies and the self-funded model for the five new projects (₹900 Crore GDV: Rashmi Paradise launching October 30; Aura, Sheetal, Royale, Aurea in pipeline) faces a funding gap.

Management's claims vs. what holds up

H1 revenue 53% YoY growth, 63% EBITDA growth, 59% PAT growth

vs. H1 delivered

₹127.64 Cr vs ₹83.39 Cr; ₹26.19 Cr EBITDA vs ₹16.05 Cr; ₹19.08 Cr PAT vs ₹12 Cr

Verdict

Supported

EBITDA margin improving from 20% Q1 to 20.96% Q2

vs. H1 delivered

Quarterly progression consistent; margin expansion evident

Verdict

Supported

Five upcoming projects, ₹900 Cr GDV, all self-funded; debt-free model intact

vs. H1 delivered

Projects named (Paradise, Aura, Sheetal, Royale, Aurea); self-funding depends on timely collections from ongoing projects

Verdict

Supported (contingent on cash timing)

Three major projects complete by March 31 FY27; no significant delays

vs. H1 delivered

Rashmi Square 80%, Signature 61%, Delight 55%, Manorath 51% complete as of Sept 30

Verdict

On track, but final-stage concentration risk remains

H1 negative cash flow due to inventory build; recovery FY28

vs. H1 delivered

-₹16.51 Cr H1 OCF; management deferred recovery from H2 FY27 to FY28

Verdict

Acknowledged (deferred timing is the real disclosure)

What changed on this call vs. Q1 guidance

Upgrades: Project pipeline expanded from 2–3 new redevelopment projects to 5 announced projects (Rashmi Paradise in Malad launching Oct 30 at ₹27–30k/sq ft; Aura, Sheetal, Royale, Aurea in pipeline). GDV target raised from ₹800 Crore to ₹900 Crore. Margin trajectory accelerated — already at 20.96% in Q2, on track for the 19–20%+ target once projects complete. Debt-free model reaffirmed; no capital raise planned. Downgrade: Cash flow recovery timing slipped. Q1 implied H2 FY27 improvement; Q2 call now guides recovery to FY28 only. Management cited inventory investment and project prepayments as the culprit — operative, not alarming, but it shifts the near-term liquidity picture from tight to tighter.

The bull-bear ledger
  • H1 revenue growth 53% YoY; EBITDA +63%; PAT +59%

  • EBITDA margin at 20.96%, expanding from 20.00% Q1; target 19–20%+ already in sight

  • ₹202 Cr sales book with ₹156 Cr revenue yet to recognize; visibility strong

  • Five new projects (₹900 Cr GDV) to be self-funded; debt-free model intact

  • H1 operating cash flow -₹16.51 Cr; recovery deferred to FY28, not H2 FY27

  • Three major projects must complete by March 31 FY27 to unlock margin and cash recovery; concentration risk

  • Per-sq-ft realization holding at ₹25,724; margin sustainability hinges on project mix and location premium

  • Smaller mid-cap redeveloper against large-cap developers; competitive moat in selectivity and execution, not scale

Risks, ranked by how much they should concern a holder

Project execution concentration (Rashmi Square, Signature, Manorath)

High

Three projects must complete by March 31 FY27 to trigger ₹200+ Cr revenue recognition and flip cash flow positive. Any 6–8 week slip cascades into FY28; cash flow recovery slips further, self-funding model for five new projects faces pressure.

Negative operating cash flow extends through H2 FY27; recovery only FY28

High

Liquidity remains constrained through March quarter. Working capital stress limits pricing flexibility and project ramp speed if a new project requires front-loaded capex before sales collections kick in.

Self-funding model assumes timely collections from ongoing projects

Medium

Five new projects (₹900 Cr GDV) depend entirely on cash from Rashmi Square, Signature, Delight, Manorath completions and collections. Buyer payment defaults or collection delays break the model; fallback is debt, contradicting core narrative.

Material cost inflation resurfaces if geopolitical tensions escalate

Low

Management confident costs now stable post-war spike. But ₹25,724/sq-ft realization is sticky; if material costs jump again, margins compress unless buyers absorb higher pricing (unlikely in competitive micro-market).

Redevelopment model is smaller-parcel focused; exposure to large-cap competition on bigger land deals

Low

Modis targets projects >1 acre (5,000+ sq meter) but explicitly avoids the biggest parcels. Godrej, Oberoi, Lodha dominate large-land redevelopment; if Modis tries to scale up, competitive intensity and capex rise.

How the street is positioned

The stock is trading at ₹383.05 as of 2026-10-28, down 11.66% from its all-time high of ₹433.60, but up 38.79% off its 52-week low of ₹276. It's sitting above its SMA50 (₹380.65) and SMA200 (₹351.34), suggesting intermediate support and a positive longer-term trend, though RSI at 48.8 is neutral — no oversold bounce setup, no overbought exhaustion. Volume is normal. FII ownership has ticked up from 8.82% (Q4 FY26) to 9.50% (Q1 FY27), a modest +68 bps increase, while DII crept from 1.16% to 1.37% (+21 bps). Promoter holding steady at 63.79%, showing no dilution. The slight FII buy-in post-result suggests cautious institutional confidence in the growth trajectory, but no euphoria. Recent bulk deals reveal mixed sentiment: SHRENI SHARES sold 1,05,754 shares at ₹384.03 (near current price), suggesting some profit-taking near the highs; prior selling by the same entity at ₹370.65 and ₹365.01 hints at a pattern of trimming into rallies. The price action and modest FII uptick reconcile: institutions are adding on the margin-expansion and pipeline upside, but not aggressively — the cash flow deferral and execution concentration risk are registering as headwinds. The street is pricing this as a good operator, not a breakout.

What to watch next

The next 3–4 catalysts
  • 1 · Rashmi Paradise launch (Oct 30, 2026)

    ₹27–30k/sq-ft pricing is the acid test for post-launch demand and per-sq-ft realization across the expanded portfolio. If it clears ₹28k on strong pre-launch bookings, it validates the pricing power narrative. Miss would flag buyer demand softening.

  • 2 · Q3 FY27 completion status (Rashmi Square, Signature, near-completion projects)

    Rasmi Square target is OC application by Dec 2026, with handover following. If delayed into Jan-Feb 2027, Q4 revenue recognition slips and so does year-end cash flow. This is the inflection hinge.

  • 3 · FY27 H2 operating cash flow (guidance to FY28)

    If cash flow improves toward zero (or positive) in Q3-Q4 FY27, FY28 recovery timeline becomes credible. Persistent negative OCF would signal collections lagging faster than expected and force the FY28 thesis.

  • 4 · FY28 guidance (Feb 2027 Q3 call)

    Management's FY28 cash flow forecast, ₹500+ Cr annual GDV delivery cadence, and margin sustainability targets will reset the valuation frame. If they maintain 19–20%+ margins and show FY28 operating cash flow positive, the narrative re-rates. If deferred further, re-rating stalls.

Modis Navnirman is executing operationally: 53% revenue growth, margin expansion, on-time project progress, debt-free model, and a funded pipeline of ₹900 Crore GDV. These are the right operating metrics. But the quarter also exposed the real constraint — not demand or margins, but liquidity. Negative H1 cash flow of -₹16.51 Crore and the deferred FY28 recovery guidance tell you that redevelopment, for all its margin upside, is front-loaded cash intensive. Management understands the profile and has built a self-funding mechanism; the bet is that collections from Rashmi Square, Signature, and three other near-completion projects will come in by March 31 FY27 and fund the five new launches. It's a reasonable bet given execution track record (14 projects delivered, zero reported delays), but it's a *bet*. The stock has priced in the margin upside and the pipeline upside; what it hasn't yet priced in is the execution concentration risk and the cash flow contingency. That's where your edge lies. Watch three things from here: Oct 30 Paradise launch pricing, Q3 completion status, and whether H2 cash flow improves toward zero. The number to track is operating cash flow — not EBITDA, not margin, cash. When that turns visibly positive, the narrative steps up a gear.

Informational and educational content only. Not investment advice.